Search Results - "Masters CL"

Transmissible spongiform encephalopathies.

Authors: Collins SJ Lawson VA Masters CL

Source: Lancet. 1/3/2004, Vol. 363 Issue 9402, p51-61. 11p.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Authors: Villain N Chételat G Grassiot B et al.

Source: Brain: A Journal of Neurology; Jul2012, Vol. 135 Issue 7, p2126-2139, 14p

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.

Authors: Fodero-Tavoletti MT Okamura N Furumoto S et al.

Source: Brain: A Journal of Neurology; Apr2011, Vol. 134 Issue 4, p1089-1100, 12p

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Authors: Chételat G Villemagne VL Pike KE et al.

Source: Brain: A Journal of Neurology; Mar2011, Vol. 134 Issue 3, p798-807, 10p

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors: Pike KE Savage G Villemagne VL et al.

Source: Brain: A Journal of Neurology; Nov2007, Vol. 130 Issue 11, p2837-2844, 8p

Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.

Authors: Evin G Sernee MF Masters CL et al.

Source: CNS Drugs. 2006, Vol. 20 Issue 5, p351-372. 22p.

Apparently sporadic CJD and covert health-care transmissions

Authors: Lewis, V Boyd, A Masters, CL et al.

Source: Lancet Neurology. Dec2002, Vol. 1 Issue 8, p470-471. 2p.

Rapid decline in episodic memory in healthy older adults with high amyloid-β.

Authors: Lim YY Pietrzak RH Ellis KA et al.

Source: Journal of Alzheimer's Disease. 2013, Vol. 33 Issue 1, p675-679. 5p.

Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.

Authors: Rembach A Doecke JD Roberts BR et al.

Source: Journal of Alzheimer's Disease. 2013, Vol. 33 Issue 1, p171-182. 12p.

Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?

Authors: Lim YY Ellis KA Harrington K et al.

Source: Journal of Alzheimer's Disease. 2013, Vol. 33 Issue 1, p1167-1176. 10p.

Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study.

Authors: Faux NG Ellis KA Porter L et al.

Source: Journal of Alzheimer's Disease. 2011, Vol. 23 Issue 1, p909-922. 14p.

Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease.

Authors: Lim NK Villemagne VL Soon CP et al.

Source: Journal of Alzheimer's Disease. 2011, Vol. 23 Issue 1, p779-786. 8p.

Increasing the Predictive Accuracy of Amyloid-[beta] Blood-Borne Biomarkers in Alzheimer's Disease.

Authors: Watt AD Perez KA Faux NG et al.

Source: Journal of Alzheimer's Disease. 2011, Vol. 23 Issue 1, p47-59. 13p.

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors: Villemagne VL Pike KE Chételat G et al.

Source: Annals of Neurology. Jan2011, Vol. 69 Issue 1, p181-192. 12p.

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.

Authors: Lui JK Laws SM Li QX et al.

Source: Journal of Alzheimer's Disease. 2010, Vol. 20 Issue 4, p1233-1242. 10p.

Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.

Authors: Chételat G Villemagne VL Bourgeat P et al.

Source: Annals of Neurology. Mar2010, Vol. 67 Issue 3, p317-324. 8p.

11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report.

Authors: Villemagne VL Pike K Pejoska S et al.

Source: Journal of Alzheimer's Disease. 2010, Vol. 19 Issue 2, p423-428. 6p.

Dopamine D(2) receptor knockout mice develop features of Parkinson disease.

Authors: Tinsley RB Bye CR Parish CL et al.

Source: Annals of Neurology. Oct2009, Vol. 66 Issue 4, p472-484. 13p.

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.

Authors: Villemagne VL McLean CA Reardon K et al.

Source: Journal of Neurology, Neurosurgery & Psychiatry. Sep2009, Vol. 80 Issue 9, p998-1001. 4p.

A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease.

Authors: Holper S Barnham KJ Churilov L et al.

Source: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2026 Apr; Vol. 22 (4), pp. e71381.

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase II

Journal Info: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE